Navigation Links
Rise Health Launches Enhanced Products, Introduces New Sales Leadership
Date:10/22/2013

Chicago, IL (PRWEB) October 22, 2013

Rise Health, Inc., a leading provider of population health analytics and patient relationship management applications, is positioning itself for aggressive growth by redefining its core product offerings and building a national sales team headed by Michael Previti, recently named Executive Vice President of Sales.

The company’s Enterprise Platform unites three distinct offerings: Ascend is an enterprise data integration platform with the ability to accept and pass data to and from multiple clinical and claims systems; Stratus, the company’s population Health Analytics application; and Cirrus Patient Relationship Manager. Combined, the product suite delivers sophisticated population health management with the ability to drill down to provide the context around each individual patient and thereby, supports clinical care coordinators and physicians in reducing costs and improving quality at the individual patient level.

“It’s one thing to gather and organize massive amounts of healthcare data and to offer sophisticated population-based reporting. But what Rise Health has accomplished is the ability to activate patients and deliver on the Triple Aim of healthcare,” says Dr. Mark Crockett, chief executive officer for Rise. “Rise Health makes a difference by pulling all of the necessary functionality together into a cohesive product suite, creating a quantifiable impact at the patient level.”

To support the launch, Rise Health has updated its corporate logo and launched a new web site that includes details on the product offering.

The company evolution and growth continues with a new sales team headed by Michael Previti. Previti comes to Rise Health from Merge Healthcare where he held multiple sales leadership positions primarily responsible for Sales Operations and Sales for both Ambulatory and Acute Care markets. Prior to his tenure at Merge, he led the Healthcare Sales Team of Initiate Systems to year over year double-digit growth before being acquired by IBM in 2010. He has steered sales organizations at a variety of blue chip healthcare information technology (HIT) companies over his 20-year career.

“Michael has demonstrated his ability to manage and build high impact sales teams to drive and deliver results,” said Dr. Crockett. “His expertise and enthusiasm, together with Rise Health’s products aimed at transforming population management and patient engagement, will propel us to our next level of growth.”

About Rise Health

Rise Health provides payers, provider organizations and healthcare information technology partners with the tools necessary to achieve the “Triple Aim” of healthcare: Improve quality, Improve patient outcomes and Lower healthcare costs. Through a vertically integrated product suite that includes Ascend Enterprise Platform, Stratus Population Health Analytics application and Cirrus Patient Relationship Manager, Rise Health offers a complete solution that closes gaps and improves operational processes at the practice. To learn more, visit http://www.risehealth.com.

Read the full story at http://www.prweb.com/releases/2013/10/prweb11252726.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. You Survived Cancer: Now Pay Attention to Your Overall Health
2. NIH awards $20 million over 5 years to train next generation of global health researchers
3. Weill Cornell Medical College establishes Center for Healthcare Informatics and Policy
4. Esophageal Cancer Surgery Can Leave Lingering Health Problems, Study Says
5. Climate Change Could Be Tough on Seniors Health: Study
6. Supporting LGB children may influence their long-term health, BU study finds
7. U.S. Spends Too Little on Public Health Initiatives: Report
8. Optimal care of bariatric surgery patients vital for long-term health and well-being
9. Timing pregnancy an important health concern for women
10. Unique approach needed to accurately assess health of young adult cancer survivors
11. Social ties have mixed impact on encouraging healthy behaviors in low-income areas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2017)... ... 25, 2017 , ... CareSet Labs released the Root NPI Graph today at ... new, greatly improved version of the Doctor Referral teaming dataset commonly available from Medicare. ... subsequently called the the “Doctor Referral Dataset” as released by Medicare and “DocGraph” as ...
(Date:6/24/2017)... ... June 24, 2017 , ... The Pennsylvania Athletic Trainers’ ... Bayfront and Erie Convention Center on June 8-10. The weekend consisted of ... bowl, award and scholarship presentations, and professional networking. , On Friday June ...
(Date:6/23/2017)... ... 2017 , ... The Rhode Island Quality Institute (RIQI) and ... Dashboards, an innovative new service enabling healthcare providers to proactively coordinate care and ... Dashboards provide near real-time data about patients admitted to and/or discharged from acute ...
(Date:6/23/2017)... ... June 24, 2017 , ... Studies show evidence that carotenoids ... risk of visual loss in these patients. , But how often do ophthalmologists and ... cessation to patients at risk of or with early symptoms of AMD? A ...
(Date:6/23/2017)... , ... June 23, 2017 , ... Everybody has their ... while others prefer to read it, and some people don't like it at all. ... Here's what they found: , Erotic literature can give readers a taste of their ...
Breaking Medicine News(10 mins):
(Date:5/26/2017)... SANTA BARBARA, Calif. , May 25, 2017 /PRNewswire-USNewswire/ ... the United States , Direct Relief is working ... of overdose-reversing Naloxone available at no cost to community ... and other nonprofit providers nationwide. "Pfizer ... expanding access to medicines and ensuring patient safety through ...
(Date:5/22/2017)... , May 22, 2017  Lilac Corp, ... Gene-Eden-VIR/Novirin, announces the launch of a new ... the results of a clinical study that showed ... treatment with Gene-Eden-VIR/Novirin in individuals suffering from HPV ... note that there are no other treatments that ...
(Date:5/18/2017)... 17, 2017  Bayer announced today that the latest ... presented at the 53 rd Annual Meeting of ... June 2-6 in Chicago . ... prostate, colorectal, liver and thyroid cancers, as well as ... II CHRONOS-1 trial of copanlisib in patients with relapsed ...
Breaking Medicine Technology: